KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to -$94.5 million.

  • Ginkgo Bioworks Holdings' Net Cash Flow rose 1723.98% to -$94.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$504.9 million, marking a year-over-year decrease of 1660.26%. This contributed to the annual value of -$383.6 million for FY2024, which is 109.41% down from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Net Cash Flow stood at -$94.5 million, which was up 1723.98% from -$104.2 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Net Cash Flow high stood at $1.5 billion for Q3 2021, and its period low was -$250.4 million during Q1 2025.
  • Its 5-year average for Net Cash Flow is -$12.1 million, with a median of -$94.5 million in 2025.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Net Cash Flow surged by 11332.82% in 2022, and later tumbled by 55767.46% in 2023.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Net Cash Flow stood at -$172.4 million in 2021, then surged by 113.33% to $23.0 million in 2022, then crashed by 557.67% to -$105.1 million in 2023, then surged by 47.0% to -$55.7 million in 2024, then tumbled by 69.56% to -$94.5 million in 2025.
  • Its Net Cash Flow was -$94.5 million in Q3 2025, compared to -$104.2 million in Q2 2025 and -$250.4 million in Q1 2025.